Concepedia

Belinda Ha

BH

24

Publications

1.7K

Citations

17

H-Index

1987

Active since

Affiliations

Research Triangle Park Foundation(Current)

Gilead Sciences (United States)

Harvard University

GlaxoSmithKline (United States)

The Lundquist Institute

Belinda Ha is an author at Research Triangle Park Foundation specializing in medicine, hiv, and drug resistance.

Top concepts

Publications per year

1987–2023

24

Publications

24

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Grace A. McComsey, Douglas Kitch, Eric S. Daar et al. · The Journal of Infectious Diseases · 2011 · 495 citations · Full text

Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

Paul E. Sax, Camlin Tierney, Ann C. Collier et al. · New England Journal of Medicine · 2009 · 313 citations · Full text

Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results

Paul E. Sax, Camlin Tierney, Ann C. Collier et al. · The Journal of Infectious Diseases · 2011 · 176 citations · Full text

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

Grace A. McComsey, Douglas Kitch, Eric S. Daar et al. · AIDS · 2012 · 93 citations · Full text

Long-term body composition changes in antiretroviral-treated HIV-infected individuals

Philip Grant, Douglas Kitch, Grace A. McComsey et al. · AIDS · 2016 · 84 citations · Full text

Rows per page

1–5 of 24